BioSpace News Archive

Fresenius Medical Care, the world’s leading provider of dialysis products and services, has released an advisory calling for clinical care principles on access to be upheld for patients with advanced chronic kidney disease if a surge in COVID-19 infections overwhelms the available supply of facilities, caregivers and ventilators.

Seneca Biopharma, Inc. (Nasdaq: SNCA), a clinical-stage biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today announced that the company held a Type C meeting with the Office of Tissues and Advanced Therapies at the FDA on March 10, 2020 to discuss future clinical developme

OraSure Technologies, Inc. has scheduled its regular earnings conference call covering 2020 first quarter financial results, updated financial guidance and certain business developments for 5:00 pm ET on Wednesday, May 6, 2020..

Updated Infant Fecal pH Range Identifies Deficiency of Beneficial Bacteria in Infant Gut Microbiome

DaVita Kidney Care stands with the National Kidney Foundation and its open letter urging hospitals and health systems not to limit care to end stage kidney disease (ESKD) patients with COVID-19 who need life-saving interventions.

Immediate order for 1,500 additional spencer® devices for Catalyst Healthcare’s network to connect through telehealth with Canada’s most vulnerable patients

PHASE Scientific announces the worldwide commercial launch of the PHASIFY VIRAL RNA Extraction Kit as part of its global effort to help detect and control the COVID-19 disease.

RaySearch Laboratories AB (publ) shares news that its advanced planning system for radiation therapy treatment will be adopted by Haaglanden Medical Center, Leiden University Medical Center and Haga Hospita

Cambridge Healthtech Institute, the leader in conference development and management for the life sciences industry, is pleased to introduce Geoff Pardo, Partner, Gilde Healthcare as the new host of the Medtech Talk Podcast which has over 150,000 downloads and more than 2,500 subscribers since launching in 2015.

Tauriga Sciences, Inc., a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, announced that it has commenced development for a 2nd flavor of its proprietary Cannabigerol infused version of Tauri-Gum™.